An etoposide-based regimen is necessary to treat haemophagocytic lymphohistiocytosis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1299, 2001-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy for Haemophagocytic Lymphohistiocytosis

Current Gene Therapy, Vol. 14, Iss. 6, 2014-12 ,pp. : 437-446

Bentham Science Publishers

Access to resources Recommend Favorite

Mercaptopurine: Haemophagocytic lymphohistiocytosis: case report

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 33-33

Adis International

Access to resources Recommend Favorite

Recent developments in the management of haemophagocytic lymphohistiocytosis

By Teramura Tomoko Morimoto Akira Imashuku Shinsaku Hibi Shigeyoshi

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 9, 2001-09 ,pp. : 1437-1448

Informa Healthcare

Access to resources Recommend Favorite

Azathioprine: Fatal haemophagocytic lymphohistiocytosis: case report

Reactions Weekly, Vol. 1, Iss. 1423, 2012-01 ,pp. : 12-13

Adis International

Access to resources Recommend Favorite

Alemtuzumab: Haemophagocytic lymphohistiocytosis in an elderly patient: case report

Reactions Weekly, Vol. 1, Iss. 1328, 2010-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite